Location History:
- Ibaraki, JP (2007)
- Tsukuba, JP (1995 - 2008)
Company Filing History:
3 out of 1,178 
1 out of 1,858 
Years Active: 1995-2008
Title: The Innovations of Hideki Kizawa
Introduction
Hideki Kizawa is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies and polypeptides. With a total of 4 patents to his name, Kizawa's work has implications for the diagnosis and treatment of various metabolic diseases.
Latest Patents
Kizawa's latest patents focus on antibodies that bind to the A chain N-terminal peptide of insulin/IGF/relaxin family polypeptides. The inventions include polypeptides that share amino acid sequences with specific SEQ IDs, as well as DNAs encoding these polypeptides. These innovations are aimed at addressing metabolic regulation issues, such as those found in diabetes mellitus, by providing tools for diagnosis, treatment, and prevention.
Career Highlights
Throughout his career, Kizawa has worked with prominent companies in the pharmaceutical industry, including Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His experience in these organizations has allowed him to contribute to significant advancements in medical science.
Collaborations
Kizawa has collaborated with esteemed colleagues, including Masataka Harada and Kazuhiro Ogi. These partnerships have further enriched his research and development efforts.
Conclusion
Hideki Kizawa's innovative work in biotechnology continues to impact the medical field, particularly in the treatment of metabolic diseases. His contributions through patents and collaborations highlight the importance of research in advancing healthcare solutions.